Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Common Stock · CUSIP: 00773U207

Event date: 2025-06-30

Filing-level shares
414,485
Percent of class
2.0%
  • BlackRock, Inc.

    Shares: 414,485 · Class: 2.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-002470
Form type
SCHEDULE 13G/A
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Jul 16, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub